M. Weinstein

发表

von Willebrand disease (VWD): evidence‐based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA) 1

B. Yawn, T. Ortel, R. Montgomery, 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

Treatment of the bleeding tendency in uremia with cryoprecipitate.

D. Deykin, M. Weinstein, P. Janson, 1980, The New England journal of medicine.

Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double-blind randomized trial.

R. Weintraub, V. Bertele', J. Ware, 1986, The New England journal of medicine.

Bleeding time prolongation with streptokinase and its reduction with 1-desamino-8-D-arginine vasopressin.

J. Loscalzo, M. A. Rudd, M. Weinstein, 1990, Circulation.

Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura.

D. Deykin, M. Weinstein, J. Troll, 1982, The New England journal of medicine.

Effects of fresh-frozen plasma and its cryosupernatant fraction on von Willebrand factor multimeric forms in chronic relapsing thrombotic thrombocytopenic purpura

J. Moake, J. Byrnes, M. Weinstein, 1985 .

Effects of fresh-frozen plasma and its cryosupernatant fraction on von Willebrand factor multimeric forms in chronic relapsing thrombotic thrombocytopenic purpura.

J. Byrnes, M. Weinstein, J. Troll, 1985, Blood.

Case Report: Von Willebrand Factor Abnormalities and Endothelial Cell Perturbation in a Patient with Acute Thrombotic Thrombocytopenic Purpura

J. Moake, J. Koutcher, M. Weinstein, 1986 .

von Willebrand factor abnormalities and endothelial cell perturbation in a patient with acute thrombotic thrombocytopenic purpura.

J. Koutcher, M. Weinstein, J. Troll, 1986, The American journal of the medical sciences.

Optimization of the thrombin generation test components to measure potency of factor VIII concentrates

M. Weinstein, S. Shestopal, N. Jha, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

Correlation of Circulating von Willebrand Factor Levels With Cardiovascular Hemodynamics

E. Salzman, J. Ware, M. Weinstein, 1991, Circulation.

Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double-blind study.

J. Ansell, R. Lew, M. Weinstein, 1992, The Journal of thoracic and cardiovascular surgery.

Desmopressin acetate to reduce blood loss after cardiac surgery.

R. Weintraub, E. Salzman, J. Ware, 1986, The New England journal of medicine.

M(r) 6,400 aurin tricarboxylic acid directly activates platelets.

M. Kroll, M. Weinstein, M. Phillips, 1993, Thrombosis research.

Detecting factor XIa in immune globulin products: Commutability of international reference materials for traditional and global hemostasis assays

D. Scott, M. Weinstein, S. Surov, 2020, Research and practice in thrombosis and haemostasis.

Relationship between human development and disappearance of unusually large von Willebrand factor multimers from plasma.

J. Moake, K. Moise, R. Carpenter, 1989, Blood.

Fetal and neonatal von Willebrand factor (vWF) is unusually large and similar to the vWF in patients with thrombotic thrombocytopenic purpura

J. Moake, K. Moise, M. Weinstein, 1989, British journal of haematology.

Quantitative Determination of Factor‐VIII Protein by Two‐Stage Gel Electrophoresis

E. Davie, M. Weinstein, Daniel Devkin, 1976, British journal of haematology.

Quantitative Abnormality of an Aα Chain Molecular Weight Form in the Fibrinogen of Cirrhotic Patients

D. Deykin, M. Weinstein, 1978, British Journal of Haematology.

Therapy of chronic relapsing thrombotic thrombocytopenic purpura with prednisone and azathioprine

J. Moake, A. Schafer, M. Weinstein, 1985, American journal of hematology.

Abnormal VIII: von Willebrand factor patterns in the plasma of patients with the hemolytic-uremic syndrome.

J. Byrnes, M. Weinstein, J. Troll, 1984, Blood.

Abnormal VIII: von Willebrand factor patterns in the plasma of patients with the hemolytic-uremic syndrome

M. Weinstein, J. Moake, C. Rudy, 1984 .

ISOLATION, SUBUNIT STRUCTURE, AND PROTEOLYTIC MODIFICATION OF BOVINE FACTOR VIII *

E. Davie, M. Weinstein, M. Legaz, 1975, Annals of the New York Academy of Sciences.

Abnormal Factor Vil Coagulant Antigen in Patients with Renal Dysfunction and in Those with Disseminated Intravascular Coagulation

K. Bauer, W. Castle, D. Deykin, 2013 .

Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass.

J. Loscalzo, S. Khuri, C. Valeri, 1995, The Annals of thoracic surgery.

Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate.

E. Salzman, J. Ware, M. Weinstein, 1988, Blood.

Heparin Causes Platelet Dysfunction and Induces Fibrinolysis Before the Institution of Cardiopulmonary Bypass

J. Loscalzo, S. Khuri, C. Valeri, 1995 .

Adventures in hemostasis. Desmopressin in cardiac surgery.

E. Salzman, J. Ware, M. Weinstein, 1993, Archives of Surgery.

Differential specificities of the thrombin, plasmin and trypsin with regard to synthetic and natural substrates and inhibitors.

M. Weinstein, R. Doolittle, Russell F. Doolittle, 1972, Biochimica et biophysica acta.

Direct radioimmune detection in human plasma of the association between factor VIII procoagulant protein and von Willebrand factor, and the interaction of von Willebrand factor-bound procoagulant VIII with platelets.

M. Weinstein, J. Troll, J. Moake, 1983, Blood.

Collaborative study for the establishment of replacement batches for human coagulation factor IX concentrate reference standards.

K. Buchheit, J. Hockley, P. Rigsby, 2008, Pharmeuropa bio.

Global Forum of the World Federation of Hemophilia, September 26-27, 2005, Montreal, Quebec, Canada.

P. Mannucci, M. Skinner, J. Dodt, 2006, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Clinical and laboratory diagnosis of von Willebrand disease: A synopsis of the 2008 NHLBI/NIH guidelines

B. Yawn, T. Ortel, R. Montgomery, 2009, American journal of hematology.

Regulation of plasma for fractionation in the United States

M. Weinstein, 2018 .

Further information on the fibrin sealant conference

J. Fratantoni, J. Finlayson, M. Weinstein, 1996, Transfusion.

Desmopressin, Von Willebrand Factor and Surgery

M. Weinstein, 1993 .

Two Distinct Forms of Factor VilI Coagulant Protein in Human Plasma

M. Weinstein, L. Chute, Hematology-Hemostasis Section, 2017 .

Two distinct forms of Factor VIII coagulant protein in human plasma. Cleavage by thrombin, and differences in coagulant activity and association with von Willebrand factor.

M. Weinstein, L. Chute, 1984, The Journal of clinical investigation.

Low solubility fibrinogen examined by two-dimensional sodium dodecyl sulfate gel electrophoresis and isoelectric focusing.

D. Deykin, M. Weinstein, 1978, Thrombosis research.

Calibration of the Ph. Eur. BRP Batch 3/Mega 2 (US/FDA) standard for human coagulation factor VIII concentrate for use in the potency assay.

K. Buchheit, M. Weinstein, G. Rautmann, 2002, Pharmeuropa. Special issue biologicals.

The molecular constancy of fibrinopeptides A and B from 125 individual humans

R. Doolittle, M. Weinstein, G. Mross, 1970, Humangenetik.

Adventures in Hemostasis

E. Salzman, J. Ware, M. Weinstein, 2016 .

The A alpha chain composition of low solubility fibrinogen.

D. Deykin, M. Weinstein, 1980, Thrombosis research.

Cryoprecipitate shortens the bleeding time and reduces bleeding complications in patients with uremia.

D. Deykin, M. Weinstein, P. Janson, 1980, Transactions of the Association of American Physicians.